# Diagnostic Performance of 18F-FDG-PET and Diffusion-weighted MRI in the Assessment of Stage IB to IIB2 Cervical Squamous-cell Carcinoma Response to Concomitant Radiochemotherapy and Brachytherapy

> **NCT01663753** · NA · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 146 (actual)

## Conditions studied

- Cancer of the Uterine Cervix

## Interventions

- **DEVICE:** 18F-FDG-PET

## Key facts

- **NCT ID:** NCT01663753
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2019-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01663753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01663753, "Diagnostic Performance of 18F-FDG-PET and Diffusion-weighted MRI in the Assessment of Stage IB to IIB2 Cervical Squamous-cell Carcinoma Response to Concomitant Radiochemotherapy and Brachytherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01663753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*